摘要
嘌呤受体通过轻微的信号输入激活三磷酸腺苷(ATP)而与损伤信号传导有关联。ATP能够介导食管黏膜中HCl诱导的瞬时受体电位香草酸亚型1活化。胃食管反流病(GERD)中的TRPV1表达上调与增加的神经生长因子(NGF)和胶质延生神经营养因子(GDNF)有关。本研究旨在从基因方面确定严重的人类食管炎中嘌呤受体的表达。对侵蚀性GRED患者,无症状患者(AP)和健康者的末端食管活检进行检查。本研究使用 qPCR检测嘌呤受体 (P2X2, P2X3, P2X7, P2Y1, P2Y2, P2Y4, P2Y6 and P2Y12)、TRPV1、TRPV4、NGF和GDNF。GERD患者中P2X3和P2X7 mRNA的表达 与健康对照组(P < 0.001)和AP(P < 0.001)相比有显著增加,而 P2X2、 P2Y1、 P2Y2、P2Y4、P2Y6、P2Y12 或P2Y12 在健康对照组、AP或GERD受试者中无差别。研究发现P2X3基因表达与TRPV1 (r = 0.46, P = 0.002)、NGF (r = 0.54, P = 0.0002)和GDNF (r = 0.64, P = 0.0001) 有良好相关性。P2X7基因也与TRPV1 (r = 0.47, P = 0.002)、NGF (r = 0.32, P = 0.037)和GDNF (r = 0.42, P = 0.005)有良好相关性。结果表明慢性食管炎增加P2X3和P2X7 受体的mRNA表达,伴随着TRPV1和神经营养因子(NGF and GDNF)的上调。这些食管黏膜中的基因的改变或许调节人类食管炎的敏化。
关键词: 胃酸反流,食管炎,神经营养因子,嘌呤受体,瞬时受体电位香草酸受体
Current Molecular Medicine
Title:Evidence for Up-Regulation of Purinergic Receptor Genes Associating with TRPV1 Receptors and Neurotrophic Factors in the Inflamed Human Esophagus
Volume: 14 Issue: 9
Author(s): K.-R. Shieh, S.-C. Yang, H.-L. Tseng, C.-H. Yi, T.-T. Liu and C.-L. Chen
Affiliation:
关键词: 胃酸反流,食管炎,神经营养因子,嘌呤受体,瞬时受体电位香草酸受体
摘要: Purinergic receptors are implicated in nociceptive signaling in small primary afferents via activation of adenosine triphosphate (ATP). ATP appears to mediate HCl-induced transient receptor potential vanilloid receptor 1 (TRPV1) activation in esophageal mucosa. Up-regulation of TRPV1 expression in gastroesophageal reflux disease (GERD) is associated with increased nerve growth factor (NGF) and glial derived neurotrophic factor (GDNF). This study aims to genetically determine the expression of purinergic receptors in severe inflamed human esophagus. Distal esophageal biopsies from the subjects with erosive GERD, asymptomatic patients (AP) and healthy ones were examined. Using real-time qPCR for detecting purinergic receptors (P2X2, P2X3, P2X7, P2Y1, P2Y2, P2Y4, P2Y6 and P2Y12), TRPV1, TRPV4, NGF, and GDNF was done in this study. Both P2X3 and P2X7 mRNA expressions in GERD patients significantly increased than those in healthy controls (P < 0.001) and AP (P < 0.001), but P2X2, P2Y1, P2Y2, P2Y4, P2Y6, P2Y12 or P2Y12 had no difference within the control, AP or GERD subjects. The well correlated expression in P2X3 gene with TRPV1 (r = 0.46, P = 0.002), NGF (r = 0.54, P = 0.0002), and GDNF (r = 0.64, P = 0.0001) was found. The P2X7 gene expressions also well correlated with TRPV1 (r = 0.47, P = 0.002), NGF (r = 0.32, P = 0.037), and GDNF (r = 0.42, P = 0.005). These results suggest that chronic esophagitis increases mRNA expressions of P2X3 and P2X7 receptors accompanied by up-regulation of TRPV1 and neurotrophic factors (NGF and GDNF). These genetical alterations in esophageal mucosa might mediate sensitization of inflamed human esophagus.
Export Options
About this article
Cite this article as:
K.-R. Shieh, S.-C. Yang, H.-L. Tseng, C.-H. Yi, T.-T. Liu and Chen C.-L., Evidence for Up-Regulation of Purinergic Receptor Genes Associating with TRPV1 Receptors and Neurotrophic Factors in the Inflamed Human Esophagus, Current Molecular Medicine 2014; 14 (9) . https://dx.doi.org/10.2174/1566524014666141021145419
DOI https://dx.doi.org/10.2174/1566524014666141021145419 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Deep Penetration of Nanoparticulate Drug Delivery Systems into Tumors: Challenges and Solutions
Current Medicinal Chemistry Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery Childhood Solitary Cutaneous Mastocytoma: Clinical Manifestations, Diagnosis, Evaluation, and Management
Current Pediatric Reviews Small Molecule Inhibitors of Stat3 Signaling Pathway
Current Cancer Drug Targets Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Current Cancer Drug Targets Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection
Current Drug Metabolism Drug-Mediated Targeted Disruption of Multiple Protein Activities Through Functional Inhibition of the Hsp90 Chaperone Complex
Current Medicinal Chemistry Pixuvri<sup>®</sup> (Pixantrone Dimaleate, BBR 2778): From Lab to Market
Current Organic Chemistry A Link Between Chemical Structure and Biological Activity in Triterpenoids
Recent Patents on Anti-Cancer Drug Discovery Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Current Pharmaceutical Design Regulation of Angiogenesis by Macrophages, Dendritic Cells, and Circulating Myelomonocytic Cells
Current Pharmaceutical Design Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
Clinical Cancer Drugs Internal Ribosome Entry Site Elements in Eukaryotic Genomes
Current Genomics GIST and Breast Cancer: 3 Case Reports and a Review of the Literature
Current Cancer Therapy Reviews High-throughput Screening Identifies Small Molecule Inhibitors of Molecular Chaperones
Current Pharmaceutical Design Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways
Current Neuropharmacology Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells
Current Cancer Drug Targets <i>In Silico</i> Approach to Predict the SARS-COV2 Derived Candidate MiRNAs as a Potential Antiviral Therapy
Current Drug Therapy Comparison of Physicochemical Properties of Generic Doxorubicin HCl Liposome Injection with the Reference Listed Drug
Anti-Cancer Agents in Medicinal Chemistry Fluorescent SNAP-Tag Galectin Fusion Proteins as Novel Tools in Glycobiology
Current Pharmaceutical Design